Anhydrous Calcium Folinate

5 trials 4 recruiting VVarious

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

1 Completed trials

5 Sponsors

8 Countries

Phase III

Phase II

Phase I/II

Phase III: 1 Phase II: 3 Phase I/II: 1

Indications tested

Colorectal cancer 1 Kearns-Sayre syndrome 1

Sponsors using this IMP

Gercor 1 Hopital Erasme 1 Janssen - Cilag International 1 Merck Sharp & Dohme LLC 1 Universitaetsmedizin Goettingen 1

All trials

5 total

Folinic acid therapy in patients with Kearns-Sayre syndrome (KSS) and cerebral folate deficiency - mitoFolat Recruiting

2023-503730-45-00 Phase II 1 country Universitaetsmedizin Goettingen
Gut microbiome intervention with EXL01 in combination with nivolumab and FOLFOX as first-line treatment for patients with PD-L1 CPS ≥5 metas… Recruiting

2023-506753-38-00 Phase II 1 country Gercor
Preoperative treatment with mFOLFIRINOX (or Gem-Nab-P) +/- isotoxic high-dose Stereotactic Body Radiation Therapy (iHD-SBRT) for borderline … Recruiting

2022-501181-22-01 Phase II 1 country Hopital Erasme
A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants with Advanced or … Recruiting

2023-506517-22-00 Phase I/II 4 countries Janssen - Cilag International
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal … Ended

2022-501342-29-00 Phase III 6 countries Merck Sharp & Dohme LLC

Showing 1–5 of 5 trials

← All drugs A–Z